Astera Labs, Inc. was upgraded to a Hold rating following a sharp post-IPO selloff that made its stock valuation expensive but less extreme. The company reported impressive Q3 results with 153.6% year-over-year revenue growth, strong operating leverage, and a significant beat and raise on guidance. However, competitive threats from Marvell's optics push and reliance on a few key customers for near-term growth pose risks. Investors should also watch cash flow quality, rising receivables and inventory, and dependency on Amazon despite management's strong execution.
Astera Labs shares have seen a significant selloff on Pluang, with order activity at 100% sell and the stock down 6.46% in one day. The price is currently USD 218.53, well below its 52-week high of USD 483.02. This data is as of Nov 05, 2026 00:41 WIB.
Astera Labs reported better-than-expected earnings and revenue, along with a fourth-quarter forecast that exceeded Wall Street's expectations. Despite these positive results, its stock price fell alongside other semiconductor stocks. The decline sugg...
Astera Labs announced record Q3 2026 revenue of $584.9 million, a 49% increase from the previous quarter and 154% year-over-year growth, led by high-volume production of its Scorpio X-Series fabric switches. The company expanded its product portfolio...
Credo reported a strong fiscal Q1 2027 with 114.7% revenue growth to $479 million and beat EPS estimates for the eighth consecutive quarter. Despite this, its stock fell nearly 20% in the past month but still trades at a discount compared to peers li...
